EAST WINDSOR, N.J. — Aurobindo Pharma USA (Aurobindo) has proposed the acquisition of Lannett Co. (Lannett). The company says it anticipates closing the acquisition towards the middle of calendar 2026, subject to regulatory approval.
"Over the coming months, we will be providing additional updates on this exciting acquisition and how we expect it to enable us to better serve you, our valued customer," said Paul McMahon, president, APUSA Oral Solids Division at Aurobindo. "In the meantime, until the transaction closes, it will be business as usual in every respect with both Aurobindo and Lannett continuing to operate as separate entities. Please continue to work with your respective points of contact at Aurobindo and Lannett for any of your normal day-to-day business needs regarding the respective product portfolios, operational and transactional matters, etc," he added.
Aurobindo to purchase Lannett Co.
The company says it anticipates closing the acquisition towards the middle of calendar 2026, subject to regulatory approval.
Latest
Audien Hearing expands reach through Costco.com launch
Costco.com debut brings Audien’s O-T-C hearing aids and personalized support to millions of members nationwide.
Ferrero Halloween poll: Adults are reclaiming Halloween and want it made official
'Adultoween' goes global — adults in Canada, the UK and Australia are also claiming Halloween and the hottest plan for the night isn't a party, it's candy and a binge-watch at home
Robox AI sees opportunity for smarter loss prevention in drug stores
According to Solomon, AI changes that dynamic by enabling retailers to analyze multiple camera feeds simultaneously and identify behavioral patterns in real time.
Crest rolls out new Crest Sensitivity Relief Toothpaste
Designed to treat the root causes of tooth sensitivity.